• Electronic Informed Consent and Enrollment Form

    Electronic Informed Consent and Enrollment Form

  • Research Subject Consent Form

    Sponsor / Study Title: 

    Ruby Neurotech / "Prospective, Single-blind, Study of a Self-Administered Digital Therapeutic Intervention Incorporating Artificial Intelligence for Instruction and Neurophysiology for Affective and Cognitive Monitoring and its Potential Effectiveness in Reducing Intrusive Memories Tested in an Analogue Model of Psychological Trauma”

    Protocol Number: RN002

    Principal Investigator: Mark Chevillet, Ph.D.

    Telephone: +1 408-493-0418 (24 Hours)

    Address: Ruby Neurotech, 2000 Broadway Street, Suite 370, Redwood City, CA 94063

    Taking part in this research is voluntary. You may decide not to participate, or you may leave the study at any time. Your decision will not result in any penalty or loss of benefits to which you are otherwise entitled.
     
    If you have any questions, concerns, or complaints or think this research has hurt you, talk to the study team at the phone number(s) listed in this document.
     
    An investigator on this study has an ownership interest in Ruby Neurotech, the
    company sponsoring this research study. As a result, the investigator may benefit financially from a successful study. Please speak with your study doctor if you have questions about this.


    RESEARCH CONSENT SUMMARY


    You are being asked for your consent to take part in a research study. This document provides a concise summary of this research. It describes the detailed information that we believe most people need in order to decide whether to take part in this research.


    What should I know about this research?


    ·      Someone will explain this research to you.
    ·      Taking part in this research is voluntary. Whether you take part is up to you.
    ·      If you don’t take part, it won’t be held against you.
    ·      You can take part now and later drop out, and it won’t be held against you.
    ·      If you don’t understand, ask questions.
    ·      Ask all the questions you want before you decide.

     
    How long will I be in this research?


    Approximately one week.


    Why is this research being done?


    To enable development of a novel digital cognitive therapy intended to prevent or reduce intrusive memories – visual images that come to mind involuntarily and cause distress in people who have experienced a psychologically traumatic event.
     

    What happens to me if I agree to take part in this research?


    If you decide to take part in this research study, you will be required to:

    • Provide informed consent and personal information necessary for enrollment.
    • Participate in an in-person study session in which:
      • you will be asked to view video content that you may find distressing.
      • you will be asked to follow instructions to complete tasks on a computer.
      • data will be recorded from sensors placed on the body, as well as the computer keyboard, mouse, microphone, and camera.
      • Remotely keep an electronic diary for a week using a personal electronic device and internet connection.

     
    Could being in this research hurt me?


    There are no risks of participating in this study that exceed those of typical daily life.


    Will being in this research benefit me?


    You are unlikely to benefit personally from participating in this research study. 


    What other choices do I have besides taking part in this research?


    You are free to choose not to participate in the research study if you do not want to.  


    What else should I know about this research?


    This study involves the collection of personally identifiable information. Your information will be protected from disclosure to others to the extent required by law.
     
    Your name and other personal identifiers will be removed from the data.
     
    Your voice in the form of microphone recordings and face in the form of video recordings will also be collected as part of this study.
     
    Collected data from this study without your identifiers may also be used for future research, shared with collaborators or other investigators, or made public as a means of reporting results in case of published manuscripts.

  • DETAILED RESEARCH CONSENT 

    You are being invited to take part in a research study. A person who takes part in a research study is called a research subject, or research participant.
     

    What should I know about this research?

    • Someone will explain this research to you.
    • This form sums up that explanation.
    • Taking part in this research is voluntary. Whether you take part is up to you.
    • You can choose not to take part. There will be no penalty or loss of benefits to which you are otherwise entitled.
    • You can agree to take part and later change your mind. There will be no penalty or loss of benefits to which you are otherwise entitled.
    • If you don’t understand, ask questions.
    • Ask all the questions you want before you decide.
    • There will be no cost to you to participate.

    Why is this research being done?

    The purpose of this research is to enable the development of a novel digital implementation of a cognitive therapy that is intended to treat intrusive memories in people who have experienced a psychologically traumatic event. Intrusive memories are distressing images, directly or indirectly related to the traumatic experience, that come to mind involuntarily.
     
    Previous research has shown that intrusive memories after experiencing trauma may be prevented or reduced through the applications of a novel cognitive therapy. In this therapeutic intervention, intrusive memories are briefly recalled, followed by an engaging cognitive task intended to activate parts of the brain associated with visual imagery and working memory. This study is intended to facilitate early development of an automated version of this therapy that can potentially be safely and effectively self-administered.
     
    To test the potential effectiveness of this digital therapeutic in preventing or reducing intrusive memories, this research study will simulate the occurrence of intrusive memories in healthy participants. This is accomplished using video content that participants may find distressing, after which participants may experience mild intrusive memories for a short period of time.
     
    If successful, this study could help motivate continued research studies, development, and clinical studies of the digital therapy in people experiencing intrusive memories after experiencing psychological trauma.
     
    Up to 300 subjects will take part in this research study over time.

    How long will I be in this research?

    Total time, including from joining study to completing electronic diary is expected to be approximately 1 week.

    What happens to me if I agree to take part in this research?

    If you choose to participate in this research, you may be asked to attend one (1) in-person study session lasting approximately 1-2 hours and keep an electronic diary for seven (7) days afterward. However, you may be invited to complete only the in-person session, which may not include all study activities.

    Before your in-person study session:

    • You will review the informed consent form and payment details (form, amount, and time when payment will be delivered).
    • You will have the opportunity to ask any questions you may have before signing using the contact information provided.
    • If you decide to participate, you will sign the Informed Consent Form electronically using the digital link provided. You will have the option to receive a digital copy of the signed consent form for your records.
    • You will complete a screening form to confirm that you meet the eligibility requirements. If eligibility is confirmed, you will be enrolled in the study.
    • You will complete a self-reported health survey that will include personally identifiable information (for example, name, email address), physical health information (for example, whether you wear glasses), and mental health information (for example, whether you have experienced a significant psychological trauma).
       

    In-person study session activities may include the following:

    • The data recording equipment and study tasks will be explained to you.
    • You will be seated at the study computer, and the physiological sensors will be placed on your head, ear, and/or hands by a member of the study team. The study team will confirm data are being recorded correctly and check data quality.
    • You will view a short video containing graphic content that you may find distressing, such as scenes involving actual or threatened death and serious injury.
    • You will then be asked to complete a series of tasks, including completing short surveys, either the digital intervention or a control task, and a sustained attention task.
    • You will be given instructions explaining how to make entries in your electronic diary over the following week. You will be reminded that total payment amount is dependent on successful completion of the electronic diary, and will be delivered electronically after the diary has been reviewed by the study team for completeness.
    • The physiological sensors will then be removed and your in-person visit will be complete.
       

    Following your in-person study session (if applicable):

    • For a total of 7 days, you will make entries in your electronic diary as instructed using a personal electronic device and internet connection.
    • Afterward, the study team will review your electronic diary for completeness and your payment will be delivered electronically.

    Study Participation Schedule

    Event Prior to in-person study session In-person study session After in-person study session
    Informed consent X    
    Eligibility criteria screening X    
    Enrollment surveys X    
    Study orientation and sensor placement   X  
    View distressing video content   X  
    Random assignment to either Intervention or control task   X  
    Post-intervention cognitive tasks   X  
    Diary instructions, surveys, sensor removal, and dismissal   X  
    Remote diary keeping (1 week)     X
    Adverse event monitoring     X
    Exit surveys     X

     

    In-person study sessions will be conducted by one (1) study team in one or more locations around the San Francisco Bay Area in the United States.
     

    What are my responsibilities if I take part in this research?


    If you choose to take part in this research, you will be responsible for:

    • Scheduling and attending your in-person study session. It is important that you arrive on time. If you are unable to keep your scheduled session, you will be responsible for rescheduling with the study team in advance.
    • Participate in all required study procedures during your in-person study session, including watching video content you may find distressing (if applicable).
    • Keeping the electronic diary for the 7 days following your in-person study session (if applicable).
       

    Could being in this research hurt me?


    Risks of participating in this study are not considered to be any worse than those that exceed those of typical daily life.
     
    All of the devices used to collect data in this research are commercially available and will be used according to their manufacturer’s recommended guidelines for use.
     
    The video content used in this study may cause you distress. These videos have been used in previous research studies in healthy participants with no evidence of harm. The video content is similar to other publicly available video content carrying a graphic content warning (for example. certain news footage or public service announcements, or medical training videos). If you do not want to be exposed to these videos you should not participate in this study.
     
    As part of this research, you may be required to use one or more of the following: a phone or web app/site, an electronic study diary (eDiary), or a device that tracks information about you. While using these, information about you may be collected and shared with the researchers or people outside of the study. This data might include personal health information, location, call logs, text message history, web browsing history, or social media use. A complete description of the data collection and sharing for an app, eDiary, or device can commonly be found in the Terms of Use, End User License Agreement, or Privacy Policy associated with the device. If you would like to read these documents, request a copy or instructions about how to access this information from the study investigator.
     
    While the Terms of Use, End User License Agreement, or Privacy Policy may include statements limiting your rights if you are harmed as a result of your use of the app/site, eDiary, or device in this study, you do not release the study investigator, sponsor, institution, or agents for responsibilities from mistakes. You also do not waive any of your rights as a research subject.
     
    You will have audio and video recordings taken of you for this study. It is possible that you or your voice may be recognizable and your identity may be known. The recordings will be stored for up to three years.
     
    There may be other risks of study participation that are unknown.
     

    Will being in this research benefit me?


    This study is for research purposes only. You are unlikely to benefit personally from participating in this research study. Your participation may help identify ways in which digital therapies might be used to prevent or reduce intrusive memories following psychological trauma that may eventually help others.  

     
    What other choices do I have besides taking part in this research?


    You are free to choose not to participate in the research study if you do not want to.
     
    There are no other choices offered.

  • What happens to the information collected for this research? 

    Confidentiality and Data Protection

    Your privacy is very important to the Sponsor and the study researchers, and they will expend every reasonable effort to protect your privacy in accordance with applicable law. During the study, the study Investigator and study team will collect and record in your study record sensitive information about you such as: birthdate, gender, ethnicity, self- reported medical history, your physiological data collected while performing study tasks, video and voice recordings, behavioral and other results of study procedures as described in this informed consent form. Except as required by law, your study data and study records will not include your name or other direct personal identifiers. Rather, your study samples and records will be identified by an assigned code number (the “Subject ID Code”). This code can only be tracked back to you via a master list linking the code numbers to names, which will be held by the sponsor and kept separate from the study data and study records. Although procedures are in place to protect your privacy, absolute confidentiality cannot be guaranteed.
     
    The coded data held by the Sponsor and its service providers will be stored, processed and compiled, including by manual and electronic methods. Electronic forms will be utilized in the study, called case report forms (CRFs), where your personal and sensitive information like demographics, gender, self-reported medical history etc., and other study tasks data will be recorded. These electronic forms will be stored on sponsor provided personal computers or cloud based digital repositories/storage systems (for example, Amazon Web Services, Google Drive) protected by passwords accessible only to the Investigator(s).
     
    Data recordings from the computer (including keyboard, mouse, microphone, and camera), as well as from the physiological sensors used in this study will be captured and stored without your personal identifiers on sponsor provided personal computers or cloud based digital repositories/storage systems (for example, Amazon Web Services, Google Drive), and/or on the device or cloud associated with the commercial device data collection format.
     
    The coded data and your study records may be transferred within the United States and to other countries. The coded data from this study may be used by or for Sponsor to carry out the study and future research, maybe shared with collaborators or other investigators to further this kind of research, for development of future therapy, to meet legal obligations and requirements in connection with the study and to make publications or presentations. Your name and identity will not be included in any such publications or presentations. By signing this informed consent form you are agreeing that your coded data and results may be used and disclosed as described in this informed consent form. Coded data collected in this research might be used for future research or distributed to collaborator or another investigator for future research without your consent.
     
    Your medical records and other personal information will be protected in accordance with U.S. law and any other applicable data protection laws. Your study records, data and results will likewise be stored and kept according to applicable legal requirements.
     
    Your private information and your medical record will be shared with individuals and organizations that conduct or watch over this research, including:

    • The study investigator, study team and those working for or with them
    • The research Sponsor
    • People who work with the research sponsor, its affiliates, persons and organizations working with sponsor and its affiliates
    • Government agencies, such as United States Food and Drug Administration (FDA)
    • A human research oversight authority, the Institutional Review Board (IRB), that reviewed this research

    By signing this consent form, you authorize the above organizations and individuals to access your study records and self- reported medical records for the purposes provided in this informed consent form and further agree that the IRB and regulatory authorities may make copies of such records, including those with your name on them.
     
    The Sponsor may publish the results of this research. However, your name and other identifying information will be kept confidential.
     
    The Sponsor will protect your information from disclosure to others to the extent required by law. The Sponsor cannot promise complete confidentiality.
     

    Whom to contact about this study?

    During the study, if you experience any medical problems, suffer a research-related injury, or have questions, concerns or complaints about the study such as:

    • Whom to contact in the case of a research-related injury or illness;
    • Payment or compensation for being in the study, if any;
    • Your responsibilities as a research subject;
    • Eligibility to participate in the study;
    • The Investigator’s or study site’s decision to withdraw you from participation;
    • Results of tests and/or procedures;

    Please contact the Investigator at the telephone number listed on the first page of this consent document.
     
    If you seek emergency care, or hospitalization is required, alert the treating physician that you are participating in this research study.
     
    An institutional review board (IRB) is an independent committee established to help protect the rights of research subjects. If you have any questions about your rights as a research subject, contact:
     

    • By mail:
      Study Subject Adviser
      Advarra IRB
      6100 Merriweather Dr., Suite 600
      Columbia, MD 21044
    • or call toll free:    877-992-4724
    • or by email:          adviser@advarra.com
       

    Please reference the following number when contacting the Study Subject Adviser: Pro00073795.
     

    What if I am injured because of taking part in this research?

    If you are injured or get sick because of being in this research, you need to seek medical attention immediately, as you normally would. Your insurance may be billed for this treatment. The sponsor will pay any charges that are not covered by insurance policy or the government, provided the injury was not due to an underlying illness or condition and was not caused by you or some other third party. No other payment is routinely available from the study Investigator or sponsor. If you are injured as a result of this study, you do not give up your right to pursue a claim through the legal system.
     
    To pay medical expenses, the sponsor will need to know some information about you like your name, date of birth, and Medicare Beneficiary Identifier (MBI). This is because the sponsor has to check to see if you receive Medicare and if you do, report the payment it makes to Medicare.
     

    Can I be removed from this research without my approval?

    The person in charge of this research can remove you from this research without your approval. Possible reasons for removal include:

    • It is in your best interest
    • You have a side effect that requires stopping the research
    • You are unable or unwilling to comply with placement of physiological sensors
    • You are unable or unwilling to view potentially aversive and distressing video content
    • You are unable to remain relatively still in a seated position for up to one hour throughout data collection
    • The research is canceled by a government agency with human clinical research oversight authority or the sponsor
    • You are unable to keep your scheduled appointments
       

    We will tell you about any new information that may affect your health, welfare, or choice to stay in this research.
     

    What happens if I agree to be in this research, but I change my mind later?

    You may decide at any time to leave the study. Simply contact the study team and asked to be withdrawn. Your research data will continue to be used up to the date of withdrawal.
     
    There is no penalty to you for withdrawing from the study.
     

    Will I be paid for taking part in this research?

    You will be paid for taking part in this research.
     
    You will earn a total of $50 for completing the in-person session, which is expected to last about 1-2 hours. You will earn $100 for remotely completing the electronic diary entries as instructed for the full 7 days following your in-person study session. You will be paid at the end of your participation in the research study after your diary has been reviewed for completeness.
     
    If you choose to stop participating during your in-person visit, you will be paid $20 per hour for your time spent prior to stopping (in 15 minute increments). If you choose to stop participating after completing your in-person session, but before completing the full 7 days of diary entries, you will be paid $50. If you successfully complete both the in-person study session and the full 7 days of diary entries, you will be paid the full $150.
     

    Participants invited to complete only the in-person session will not be asked to complete the electronic diary and will receive compensation only for the in-person session. 


    As appropriate, you may also be given a payment code for a ride sharing service or have your reasonable travel costs associated with participating in the study reimbursed in addition to your payment for participation.
     
    Payment will be provided electronically (for example, Zelle, PayPal) using your recorded email address in one lump sum after electronic diary entries have been reviewed for completeness.

  • STATEMENT OF CONSENT

    I have read and understand the information in this informed consent document. I have had an opportunity to ask questions and all of my questions have been answered to my satisfaction. I voluntarily agree to participate in this study until I decide otherwise. I do not give up any of my legal rights by signing this consent document. I will receive a copy of this signed consent document.

    Your signature documents your consent to take part in this research.

  • Powered by Jotform SignClear
  •  - -
  • Image-47
  •  - -
  • Participant Requirements:

  • The Google Sheets App is required to participate in this study. Please use the links to below to download Google Sheets if you do not have the app already:

    iOS: https://apps.apple.com/us/app/google-sheets/

    Android: https://play.google.com/store/apps/

  • Participant Acknowledgement:

  • Powered by Jotform SignClear
  • Eligibility Screening

  • Demographic Information

  • Additional Information

  •  
  • Should be Empty: